2021 AHA科学声明:体育锻炼作为高血压或胆固醇升高一线治疗的重要组成

2021-06-02 美国心脏协会 Hypertension. 2021 Jun 2;

2021年6月,美国心脏协会(AHA)发布了体育锻炼作为高血压或胆固醇升高一线治疗的重要组成的科学声明。当前指南广泛推荐了生活方式作为预防和治疗高血压和胆固醇升高的方法,对于血压和胆固醇轻度升高的患者

中文标题:

2021 AHA科学声明:体育锻炼作为高血压或胆固醇升高一线治疗的重要组成

英文标题:

Physical Activity as a Critical Component of First-Line Treatment for Elevated Blood Pressure or Cholesterol: Who, What, and How?: A Scientific Statement From the American Heart Association

发布机构:

美国心脏协会

发布日期:

2021-06-02

简要介绍:

2021年6月,美国心脏协会(AHA)发布了体育锻炼作为高血压或胆固醇升高一线治疗的重要组成的科学声明。当前指南广泛推荐了生活方式作为预防和治疗高血压和胆固醇升高的方法,对于血压和胆固醇轻度升高的患者,单纯生活方式改善是一线治疗方法。本文介绍了体育锻炼作为高血压或胆固醇升高一线治疗的重要组成的相关建议。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 AHA科学声明:体育锻炼作为高血压或胆固醇升高一线治疗的重要组成.pdf)] GetToolGuiderByIdResponse(projectId=1, id=1b2f31c00211a68c, title=2021 AHA科学声明:体育锻炼作为高血压或胆固醇升高一线治疗的重要组成, enTitle=Physical Activity as a Critical Component of First-Line Treatment for Elevated Blood Pressure or Cholesterol: Who, What, and How?: A Scientific Statement From the American Heart Association, guiderFrom=Hypertension. 2021 Jun 2;, authorId=0, author=, summary=2021年6月,美国心脏协会(AHA)发布了体育锻炼作为高血压或胆固醇升高一线治疗的重要组成的科学声明。当前指南广泛推荐了生活方式作为预防和治疗高血压和胆固醇升高的方法,对于血压和胆固醇轻度升高的患者, cover=https://img.medsci.cn/2021623/1624436556948_2020535.jpg, journalId=0, articlesId=null, associationId=60, associationName=美国心脏协会, associationIntro=美国心脏协会(AHA,American Heart Association)是心脏病学领域比较正要的学会之一,致力于心脏病和卒中的预防与治疗,提供相关继续教育、流行病学年度报告。每年举办学术年会报道中的的临床试验结果等,有官方杂志《美国心脏协会杂志》,提供心血管疾病和卒中相关的指南及专家共识,更新的比较快。, copyright=0, guiderPublishedTime=Wed Jun 02 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年6月,美国心脏协会(AHA)发布了体育锻炼作为高血压或胆固醇升高一线治疗的重要组成的科学声明。当前指南广泛推荐了生活方式作为预防和治疗高血压和胆固醇升高的方法,对于血压和胆固醇轻度升高的患者,单纯生活方式改善是一线治疗方法。本文介绍了体育锻炼作为高血压或胆固醇升高一线治疗的重要组成的相关建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=274, tagName=高血压), TagDto(tagId=88696, tagName=胆固醇升高)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=274, guiderKeyword=高血压, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3057, appHits=103, showAppHits=0, pcHits=425, showPcHits=2954, likes=0, shares=12, comments=9, approvalStatus=1, publishedTime=Wed Jun 23 17:23:35 CST 2021, publishedTimeString=2021-06-02, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Jun 23 16:22:42 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Thu Jan 04 18:47:02 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 AHA科学声明:体育锻炼作为高血压或胆固醇升高一线治疗的重要组成.pdf)])
2021 AHA科学声明:体育锻炼作为高血压或胆固醇升高一线治疗的重要组成.pdf
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1057575, encodeId=39f7105e575a3, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:25:45 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006860, encodeId=0467100686010, content=已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e05569940, createdName=ms5000001906902679, createdTime=Wed Aug 11 09:06:08 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006858, encodeId=9bf21006858bb, content=已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e05569940, createdName=ms5000001906902679, createdTime=Wed Aug 11 08:54:51 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976351, encodeId=7b519e63511b, content=Mark, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/e9400b10040c42c19853620456dabe53/b137ed05fedf4c1b9bf132fd567c1670.jpg, createdBy=0eed5532793, createdName=丫丫笑笑, createdTime=Wed Jun 23 22:30:20 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976288, encodeId=b4a69e6288ad, content=很有用!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03a94799581, createdName=75505628, createdTime=Wed Jun 23 19:18:25 CST 2021, time=2021-06-23, status=1, ipAttribution=)]
    2021-10-04 H8888888

    不错 谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1057575, encodeId=39f7105e575a3, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:25:45 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006860, encodeId=0467100686010, content=已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e05569940, createdName=ms5000001906902679, createdTime=Wed Aug 11 09:06:08 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006858, encodeId=9bf21006858bb, content=已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e05569940, createdName=ms5000001906902679, createdTime=Wed Aug 11 08:54:51 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976351, encodeId=7b519e63511b, content=Mark, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/e9400b10040c42c19853620456dabe53/b137ed05fedf4c1b9bf132fd567c1670.jpg, createdBy=0eed5532793, createdName=丫丫笑笑, createdTime=Wed Jun 23 22:30:20 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976288, encodeId=b4a69e6288ad, content=很有用!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03a94799581, createdName=75505628, createdTime=Wed Jun 23 19:18:25 CST 2021, time=2021-06-23, status=1, ipAttribution=)]
    2021-08-11 ms5000001906902679

    已学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1057575, encodeId=39f7105e575a3, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:25:45 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006860, encodeId=0467100686010, content=已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e05569940, createdName=ms5000001906902679, createdTime=Wed Aug 11 09:06:08 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006858, encodeId=9bf21006858bb, content=已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e05569940, createdName=ms5000001906902679, createdTime=Wed Aug 11 08:54:51 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976351, encodeId=7b519e63511b, content=Mark, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/e9400b10040c42c19853620456dabe53/b137ed05fedf4c1b9bf132fd567c1670.jpg, createdBy=0eed5532793, createdName=丫丫笑笑, createdTime=Wed Jun 23 22:30:20 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976288, encodeId=b4a69e6288ad, content=很有用!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03a94799581, createdName=75505628, createdTime=Wed Jun 23 19:18:25 CST 2021, time=2021-06-23, status=1, ipAttribution=)]
    2021-08-11 ms5000001906902679

    已学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1057575, encodeId=39f7105e575a3, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:25:45 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006860, encodeId=0467100686010, content=已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e05569940, createdName=ms5000001906902679, createdTime=Wed Aug 11 09:06:08 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006858, encodeId=9bf21006858bb, content=已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e05569940, createdName=ms5000001906902679, createdTime=Wed Aug 11 08:54:51 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976351, encodeId=7b519e63511b, content=Mark, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/e9400b10040c42c19853620456dabe53/b137ed05fedf4c1b9bf132fd567c1670.jpg, createdBy=0eed5532793, createdName=丫丫笑笑, createdTime=Wed Jun 23 22:30:20 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976288, encodeId=b4a69e6288ad, content=很有用!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03a94799581, createdName=75505628, createdTime=Wed Jun 23 19:18:25 CST 2021, time=2021-06-23, status=1, ipAttribution=)]
    2021-06-23 丫丫笑笑

    Mark

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1057575, encodeId=39f7105e575a3, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:25:45 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006860, encodeId=0467100686010, content=已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e05569940, createdName=ms5000001906902679, createdTime=Wed Aug 11 09:06:08 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006858, encodeId=9bf21006858bb, content=已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e05569940, createdName=ms5000001906902679, createdTime=Wed Aug 11 08:54:51 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976351, encodeId=7b519e63511b, content=Mark, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210629/e9400b10040c42c19853620456dabe53/b137ed05fedf4c1b9bf132fd567c1670.jpg, createdBy=0eed5532793, createdName=丫丫笑笑, createdTime=Wed Jun 23 22:30:20 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976288, encodeId=b4a69e6288ad, content=很有用!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03a94799581, createdName=75505628, createdTime=Wed Jun 23 19:18:25 CST 2021, time=2021-06-23, status=1, ipAttribution=)]
    2021-06-23 75505628

    很有用!

    0

拓展阅读

2009ESH 欧洲高血压指南重新评估

欧洲高血压学会(ESH,European Society of Hypertension) · 2009-11-01

2010 台湾高血压管理指南(英文版)

台湾心脏病学会(TSOC,Taiwan Society of Cardiology) · 2010-01-01

2010年中国肺高血压诊治指南

中华医学会心血管病学分会(Chinese Society of Cardiology) · 2010-01-01

2010高血压患者胆固醇管理临床指导建议

中国心血管相关专家小组(统称) · 2010-02-01

2009年基层版《中国高血压防治指南》

中华人民共和国卫生部(MINISTRY OF HEALTH OF THE PEOPLE`S REPUBLIC OF CHINA) · 2010-02-10

2010 中国急诊高血压管理专家共识

中国医师协会急诊医师分会(CHINESE COLLEGE OF EMERGENCY PHYSICANS,CCEP) · 2010-03-19